Pharmaceutical giant Merck & Co. announced Nov. 18 that Thomas H. Glocer plans to retire from the company’s board of directors at Merck’s annual shareholders’ meeting in May 2027.
The independent members of the board have appointed Douglas M. Baker, Jr., as independent lead director, effective Jan. 1, 2027, succeeding Glocer.